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Abstract
Introduction and hypothesis The objective was to determine
predictors of long-term success in women with stress urinary
incontinence (SUI) treated with a 3-month pelvic floor muscle
training (PFMT) program delivered via the Internet or a
brochure.
Methods We included 169 women with SUI ≥1 time/week
who completed the 1-year follow-up (n= 169, mean age
50.3, SD 10.1 years). Three outcome variables defined suc-
cess after 1 year: Patient Global Impression of Improvement
(PGI-I), International Consultation on Incontinence Modular
Questionnaire Urinary Incontinence Short Form (ICIQ-UI
SF), and sufficient treatment. Using logistic regression, we
analyzed data from the baseline, and from the 4-month and
1-year follow-ups, for potential predictors of success.
Results Of the participants, 77 % (129 out of 169) were suc-
cessful in ≥1 of the outcomes, 23 % (37 out of 160) were
successful in all 3. Participants with successful short-term re-
sults were more likely to succeed in the corresponding out-
come at 1 year than those without successful short-term results
(adjusted odds ratios [ORs]: PGI 5.15, 95 % confidence inter-
val [CI] 2.40–11.03), ICIQ-UI SF 6.85 (95 % CI 2.83–16.58),
and sufficient treatment 3.78 (95 % CI 1.58–9.08). Increasing
age predicted success in PGI-I and sufficient treatment (ad-
justed OR 1.06, 95 % CI 1.02–1.10, and 1.08, 95 % CI, 1.03–
1.13 respectively). Compared with not training regularly, reg-
ular PFMT at 1 year predicted success for PGI and sufficient
treatment (adjusted OR 2.32, 95 % CI 1.04–5.20, and 2.99,
95 % CI 1.23–7.27 respectively).
Conclusion The long-term success of a non-face-to-face treat-
ment program for SUI with a focus on PFMTcan be predicted
by successful short-term results, increasing age, and the per-
formance of regular PFMT after 1 year.
Keywords eHealth . Long-term . Pelvic floor muscle
training . Predictors . Self-management . Stress urinary
incontinence
Introduction
The most common form of incontinence in women is stress
urinary incontinence (SUI), affecting 10–35 % of women [1].
Symptoms of SUI are leakage during exertion, coughing, or
sneezing [2], and diagnosis before starting non-surgical treat-
ment in an outpatient setting can be based on the symptoms
reported by the patient [3, 4]. High BMI, older age, smoking,
parity, vaginal delivery, and weakening of the pelvic floor are
some of the known risk factors for the development of SUI [5,
6]. The first treatment of choice is pelvic floor muscle training
(PFMT) combined with lifestyle interventions, such as weight
loss if the person is overweight [7, 8]. The majority of women
with SUI report an improvement after 3 months of PFMT [3,
9] and 1 in 3 women becomes continent [4]. The long-term
success of PFMT varies between 41 and 85 % [10].
Several studies have investigated the predictors of short-
term results after PFMT, but the results have been contradic-
tory. Suggested predictors of a positive result at 3 months are
menopause, higher education, no previous urinary inconti-
nence surgery [11], poor contraction strength at baseline,
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and great improvement in pelvic floor muscle strength [12].
There is limited knowledge on the predictors of long-term
outcome, which could be useful for both patients and clini-
cians for predicting in whom PFMT will be successful and
who will need surgery.
In a recent randomized controlled trial (RCT), women with
SUI treated with non-face-to face treatment focusing on PFMT
were significantly improved at the 4-month follow-up. The im-
provements were maintained at the 1-year and 2-year follow-
ups [13, 14]. The aim of the present study was to evaluate
clinically relevant predictors of long-term success after non-
face-to-face treatment focusing on PFMT in women with SUI.
Materials and methods
Study population
The analyses in this study are based on data from an RCT
conducted between 2009 and 2011 (ID: NCT01032265).
Women were enrolled in the project via an online screening
survey that evaluated the type of incontinence and inclusion
and exclusion criteria. The inclusion criteria were: female, age
18–70 years, SUI ≥1 time/week, ability to read and write
Swedish, and access to a computer with the Internet. The
exclusion criteria were: leakage associated with urgency, pre-
vious UI surgery, pregnancy, known malignancy in the lower
abdomen, difficulties passing urine, macroscopic hematuria,
intermenstrual bleeding, severe psychiatric disorders or
Hospital Anxiety and Depression Scale (HADS) score >15
for depression or anxiety, and neurological disease affecting
sensitivity in the legs or lower abdomen. Women considered
eligible were sent self-assessment questionnaires for addition-
al evaluation, including the validated questionnaires, the
Lower Urinary Tract Symptoms Quality of Life (ICIQ-
LUTSqol) and the International Consultat ion on
Incontinence Modular Questionnaire Urinary Incontinence
Short Form (ICIQ-UI SF), medical history, and a 2-day blad-
der diary. After their completion, a telephone interview was
performed by a urotherapist to confirm the diagnosis of SUI.
A total of 250 women aged 18–70 years with SUI ≥1 time/
week were randomized by computer-generated block random-
ization to either an Internet-based training program or a pro-
gram delivered by post to compare the effect of the two pro-
grams after a 3-month treatment period. The programs
consisted of PFMT of increasing intensity three times per
day for 3 months including contractions for strength and en-
durance, quick contractions, and the Bknack maneuver^ with
information and lifestyle advice. No face-to-face education
was provided before or during the PFMT program. Follow-
up was performed at 4 months and 1 year using self-assessed
questionnaires. The RCTwas described in detail by Sjöström
et al. [13].
All women who answered the 1-year follow-up question-
naires were included in the present study (n = 169).
Participants in both groups achieved highly significant and
clinically relevant improvements in the primary outcomes
symptom severity and condition-specific quality of life, and
the groups did not significantly differ in these measures [13].
In the present study, the analyses include all participants re-
gardless of treatment group. At 1 year, 3 % of the women (5
out of 169, 3 from the postal group and 2 from the Internet
group) had undergone surgery for SUI and were also included
in the study. None of the women received newmedications for
incontinence during the study period.
Definition of success
We used three outcomes to define success after 1 year:
1. Patient Global Impression of Improvement (PGI-I), a val-
idated [15], patient-reported evaluation of the result of
treatment consisting of one question: BHow is your uri-
nary leakage now compared with before treatment?^On a
scale with seven alternatives ranging from very much
worse to very much better, participants answering that
they were much better or very much better were consid-
ered to have a successful outcome.
2. The ICIQ-UI SF is a validated and highly recommended
symptom scoring instrument [3, 8, 16] that evaluates
symptoms such as frequency, amount of leakage, and
overall inconvenience. It consists of four questions: three
adding up to a score (0–21 points) and the fourth used to
determine the type of incontinence. The minimal impor-
tant difference (MID) in improvement is the difference
between the ICIQ-UI SF score at inclusion and at fol-
low-up. An overall score reduction of 2.5 can be consid-
ered clinically relevant [17]. We used ≥3 (rounded up to
the closest integer) to define success.
3. BSufficient treatment^ is a question from the follow-up
questionnaire: BDo you currently think that the treatment
you underwent is sufficient?^ answered with BNo,^ BYes,
I am completely cured frommy urinary leakage,^ or BYes,
I think the treatment is sufficient even though I am not
completely cured.^ We considered the two answer alter-
natives beginning with Byes^ as a successful outcome.
Possible predictors
The possible predictors of long-term success we chose to an-
alyze included known risk factors for SUI [5–7] and suggested
predictors from short-term results [11, 12, 18–20]. Because
short-term success likely affects long-term success, we includ-
ed data from the 4-month follow-up [10].We also included the
amount of PFMT performed after 1 year. The data at baseline
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consisted of age, body mass index (kg/m2), education, meno-
pausal status, parity, vaginal delivery of a child ≥4,000 g, local
estrogen use, physical activity, time since onset of SUI, previ-
ously sought medical contact for SUI, ICIQ-UI SF, condition-
specific quality of life as measured by the questionnaire ICIQ-
LUTSqol, tea drinking, motivation to perform PFMT (Likert
scale 1–10), and self-rated ability to perform PFMT (Likert
scale 1–10). The data from the 4-month follow-up consisted of
PGI-I, MID ICIQ-UI SF, sufficient treatment, and MID ICIQ-
LUTSqol. The data from the 1-year follow-up concerned how
often PFMT had been performed in the last 3 months, which
could be answered with BNever,^ BSporadically, less than
once a week,^ BRegularly, 1–3 times/week,^ BRegularly,
more than 3 times/week,^ or BRegularly, daily.^
Statistical analysis
The baseline variables ICIQ-UI SF, ICIQ-LUTSqol, and age
were treated as continuous variables and the other possible
predictors as categorical variables. At the 4-month follow-
up, the possible predictors PGI-I, ICIQ-UISF, and sufficient
treatment were analyzed in the same way as at the 1-year
follow-up. The ICIQ-LUTSqol was divided into two catego-
ries based on the score reduction between inclusion and the 4-
month follow-up; a score reduction exceeding the established
MID (i.e., ≥4) [17] was considered a relevant improvement.
The categorical variables were divided into categories on the
original questionnaire. To have enough participants in each
category to proceed with analyses, we had to create fewer
categories by adding them together. The categories were re-
duced based on clinical relevance and the distribution of an-
swers for the following predictors: body mass index (kg/m2),
education, physical activity, time since onset of SUI, tea drink-
ing, motivation to perform PFMT, self-rated ability to perform
PFMT, and how often PFMT had been performed in the last
3 months at the 1-year follow-up. PFMT at 1 year was
changed into two categories in which the answers beginning
with Bregularly^ were in one category and Bnever^ or
Bsporadically, less than one time/week^ were another catego-
ry, as shown in Table 2.
The outcome variables were recoded as 1 for success and 0
for failure. The relationships between each of the potential
predictors and the outcomes were tested using the Chi-
squared test for categorical variables, independent t test for
continuous variables, and univariate logistic regression. Age
and predictors with p<0.25 were used in a final multivariate
model in which non-significant (p>0.05) predictors were
manually removed one-by-one starting with the predictor with
the highest p value, leaving only predictors with p<0.05. The
multivariate analysis was also performed without the five
women who had undergone surgery.
All statistical analyses were performed using SPSS version
22.0 software.
Ethics
The study was ethically approved by the Regional Ethical
Review Board, Umeå University (number 08-124 M and
2015-79-32 M).
Results
Of the 169 women included, 1 did not answer the PGI-I, 3 did
not complete the ICIQ-UI SF, and 7 did not answer the ques-
tion about sufficient treatment. The baseline data are summa-
rized in Table 1. The mean age was 50.3 years, less than one-
third of patients were overweight or obese, and most women
were highly educated. The mean ICIQ-UI SF score was 10.1,
which corresponds to moderate severity [21].
Table 1 Baseline characteristics of participants who completed 1-year
follow-up (n= 169)
Characteristic Data
Mean age, years (SD) 50.3 (±10.1)
BMI, n (%)
< 25 117 (69.2)
25–30 37 (21.9)
> 30 15 (8.9)
Education, n (%)
Primary and secondary 41 (24.3)
Post-secondary 128 (75.7)
Parity, mean (SD) 2.07 (±0.99)
Vaginal delivery of child weighing >4,000 g, n (%) 49 (29.0)
Use of local estrogen, n (%) 22 (13.0)
Premenopausal, n (%) 94 (55.6)
Moderate physical activity, n (%)
< 3 h/week 58 (34.3)
3–5 h/week 54 (32.0)
> 5 h/week 57 (33.7)
Duration of SUI, n (%)
< 1 year 9 (5.3)
1–5 years 70 (41.4)
> 5 years 90 (53.3)
ICIQ-UI SF, mean (SD) 10.14 (±3.20)
ICIQ-LUTSqol, mean (SD) 32.70 (±6.78)
Use of protective pads, n (%) 124 (73.4)
SD standard deviation, n number of observations, SUI stress urinary in-
continence, BMI body mass index (kg/m2 ), ICIQ-UI SF International
Consultation on Incontinence Modular Questionnaire Urinary
Incontinence Short Form, ICIQ-LUTSqol International Consultation on
Incontinence Modular Questionnaire Lower Urinary Tract Symptoms
quality of life
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Proportion of successful results after 1 year
Among the study participants, 77 % (129 out of 169) were
successful in at least one of the outcome variables. The out-
come variables corresponded to the following success rates:
PGI-I, 33 % (55 out of 168); ICIQ-UI SF, 57 % (95 out of
166); and sufficient treatment, 57 % (93 out of 162). Twenty-
three percent of the women (37 out of 160) were successful in
all three outcome variables (Fig. 1).
Of the women who were successful at the 4-month follow-
up, 55–76 % were still successful in the corresponding out-
come at 1 year. However, 20–31 % of the women who failed
at the 4-month follow-up succeeded at the 1-year follow-up
(Fig. 2).
Predictors of a successful outcome after 1 year
The possible predictors time since debut of SUI, previously
sought medical contact for SUI, education, and BMI did not
result in a p-value <0.25 in any of the outcome variables and
were not included in the multivariate analysis. The remainder
of the potential predictors had p-values <0.25 in one or more
of the outcome variables in the univariate analysis and are
presented in Table 2.
In the final multivariate regression models (Table 3), a suc-
cessful result at 4 months for each of the outcome variables
predicted a successful result at 1 year for the same outcome
variable. Increasing age and performance of regular PFMT
during the last 3 months before the 1-year follow-up remained
significant predictors in two of the outcome variables.
Physical activity had inconsistent results, and there was a
trend toward better results with less physical activity in the
outcome PGI-I, but the trend was lacking in the outcome
ICIQ-UI SF. The severity defined by ICIQ-UI SF at baseline
had contradictory results; increased severity at baseline pre-
dicted success in the outcome ICIQ-UI SF and less severe
leakage at baseline predicted success in the outcome sufficient
treatment. The self-rated ability to perform PFMT remained a
significant predictor of a successful outcome in one outcome
variable.
The results from the multivariate analysis did not change
when the 5 womenwho had undergone surgery by 1 year were
removed from the analysis.
Discussion
The main predictors of long-term success after non-face-to-
face treatment based on PFMT in women with SUI were a
successful result at 4 months, the performance of regular
PFMT after 1 year, and increasing age. The severity of incon-
tinence at baseline and physical activity had inconsistent re-
sults, and the self-rated ability to perform PFMT was only
significant in one of the outcome variables.
Strengths
The population in this study was well defined, as all women
had clinically relevant SUI with ≥1 leakage/week and actively
sought treatment. PFMT is the first choice for the treatment of
Fig. 1 Proportion of patients
with successful outcomes in the
variables BPGI-I,^ BICIQ-UI SF,^
and Bsufficient treatment^ at
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women with SUI. The outcome measures ICIQ-UI SF and
PGI-I are validated and the ICIQ-UI SF is also highly recom-
mended. The third outcome, sufficient treatment, is important
from a clinical perspective and reflects the patient’s goal of
treatment, a recommended part of the composite end-points
[22]. The possible predictors were chosen based on risk fac-
tors or findings from other studies [5, 6, 11, 12, 18–20, 23].
The percentage of women who underwent incontinence sur-
gery during follow-up (3.0 %) was lower in our study than in
other long-term studies (4.9–58 %) [10]. We included all
women who completed the follow-up, including the 5 who
had undergone surgery.We also excluded these 5 women from
the final analysis, with no effect on the results.
Limitations
A possible shortcoming of this study is the lack of an objective
outcome measure for the amount or frequency of leakage. We
chose to use patient-reported measures based on validated and
highly recommended questionnaires. Patient-reported mea-
sures are important and correlate with reduced incontinence
[24]. The losses to follow-up (32 %) are comparable with the
upper range of other long-term studies on incontinence [10].
The women who did not complete the 1-year follow-up were
younger and had more severe leakage than the women who
completed the follow-up [13]. We do not expect the losses to
follow-up to influence our results, because only the women
who answered the 1-year follow-up were included in this
study. The limited number of participants in this study may
increase the risk of type II errors (false-negative), and there
may bemore predictors that we did not find. The large number
of possible predictors that we analyzed could have created
significant results by chance.
Population and treatment
The women in this study were generally highly educated and
75.7 % had a post-secondary education, compared with 35 %
of women ≥16 years of age in the general population of
Sweden at the time of inclusion (i.e., 2009) [25]. In other
fields, studies on online prevention efforts aimed at lifestyle
changes have shown that participants are more often white,
female, highly educated, and living in high-income countries
[26]. This description fits our study population and may be
problematic for generalizing the results because of the high
education level. In short-term predictor studies, both higher
[11] and lower [20] education have been described as predic-
tors of a successful result. However, in our study, education
was not a predictor in any of the logistic regression analyses.
The NICE guidelines recommend 3 months of supervised
PFMT as the first-line treatment for SUI [8]. However,
Shamliyan et al. found no significant differences in treatment
effects regarding continence rates or discontinuation between
supervised PFMT and unsupervised PFMT [3]. The PFMT in
this program is unsupervised, but, unlike studies that compare
supervised and unsupervised PFMT [27, 28], the women in
Fig. 2 Proportion of participants with success and failure at 4months and
1 year. The 4-month follow-up only included women who answered at
the 1-year follow-up
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this study did not receive any face-to-face education by a
physiotherapist during the program. Nonetheless, the women
in our study population were significantly improved at
4 months, 1 year, and 2 years [13, 14].
Outcomes and predictors
We found that more severe incontinence was a factor that
made women more likely to achieve success based on the
ICIQ-UI SF, whereas the women with less severe inconti-
nence were more likely to reach a successful result based on
the outcome variable sufficient treatment. The literature on
severity as a short-term predictor has reported inconsistent
results, with some studies reporting that patients with a higher
incontinence frequency have poorer outcomes [11, 18, 20].
However, Hung et al. reported that women with more severe
incontinence at baseline are more likely to be successful,
based on self-reported results [12]. The choice of outcome
variables seems to be very important when analyzing severity
as a predictor. The three studies reporting poorer outcomes
with more severe incontinence used objective measures, and
the study that reported a more successful outcome with in-
creased severity used a subjective outcome measure. When
defining treatment outcomes for lower urinary tract symptoms
(LUTS), Hilton and Robinson stated that it is important to
acknowledge different perspectives. Subjective measures
and quality of life were rated highly by the clinician, patient,
and any Bthird party.^ Nevertheless, patients also found the
objective measures cost reduction and avoidance of surgery
important [22].
Our findings in relation to other findings
Our finding of a successful result at the 4-month fol-
low-up being a predictor of long-term success is com-
parable with the results in a review on long-term results
in which 7 out of 19 studies reported long-term out-
come based on short-term success; the responders to
the initial program maintained the result better than
the non-responders [10]. The results after general resis-
tance training seem to be maintained with one to two
training episodes per week after previous involvement in
training [29]. We found that regular PFMT at least once
per week during the last 3 months at the 1-year follow-
up more than doubled the OR of being successful at
1 year for sufficient treatment and PGI-I. Hung et al.
found that increased pelvic floor muscle strength, but
not PFMT adherence, was a predictor of success [12].
Furthermore, Theofrastous et al. described a reduction in
incontinence episodes after PFMT, but the correlation
between the improvement and PFMT was weak [23].
In contrast to short-term predictor studies, our results
suggest that adherence to PFMT might be important
for long-term success.
Our results indicate that increasing age is a predictor
of success at the 1-year follow-up in women. No corre-
lation has been found between age and outcome in oth-
er predictor studies (short-term) [11, 12, 18–20, 23].
Perhaps in the long-term, our outcomes benefit older
patients with regard to more successful results.
Younger women may be less accepting of incontinence
and more likely to report being unsatisfied with the
treatment, which corresponds well with the results of
Labrie et al., who found that age ≤55 years is a predic-
tor of surgery after physiotherapy [30]. Another expla-
nation may be that older women have more time to
perform the PFMT.
Table 3 Adjusted odds ratios (OR)* for a successful outcome at 1 year
OR (95 % CI) p value
PGI-I
Predictive model (Nagelkerke R2 0.30)
Age (years) 1.06 (1.02–1.10) <0.001
Moderate physical activity
< 3 h/week 1.00
3–5 h/week 0.37 (0.14–0.93) 0.04
> 5 h/week 0.28 (0.11–0.75) 0.01
PGI-I, 4-month follow-up
Little better/much worse 1.00
Much better/very much better 5.15 (2.40–11.03) <0.001
PFMT last 3 months, at 1-year follow-up
Less than once a week 1.00
At least once per week 2.32 (1.04–5.20) 0.04
ICIQ-UI SF
Predictive model (Nagelkerke R2 0.51)
ICIQ-UI SF, at baseline 1.43 (1.22–1.67) <0.001
Self-rated ability to perform PFMT
1–9 1.00
10 3.04 (1.31–7.08) 0.01
Moderate physical activity
< 3 h/week 1.00
3–5 h/week 0.27 (0.10–0.76) 0.01
> 5 h/week 1.02 (0.38–2.76) 0.97
MID ICIQ-UI SF, 4-month follow-up
< 3 1.00
≥ 3 6.85 (2.83–16.58) <0.001
Sufficient treatment
Predictive model (Nagelkerke R2 0.45)
Age (years) 1.08 (1.03–1.13) <0.001
ICIQ-UI SF, at baseline 0.86 (0.75–0.98) 0.03
PGI-I, 4-month follow-up
Little better/much worse 1.00
Much better/very much better 3.05 (1.18–7.84) 0.02
Sufficient treatment, 4-month follow-up
No 1.00
Yes 3.78 (1.58–9.08) <0.001
PFMT last 3 months at 1-year follow-up
Less than 1 time/week 1.00
Regularly, at least 1 time /week 2.99 (1.23–7.27) 0.02
*Adjusted for age and predictors with a p value <0.25 in the univariate
logistic regression analysis
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Clinical implications
More research and longer follow-ups are needed to fur-
ther evaluate predictors of long-term success and devel-
op specific recommendations for women with SUI. Even
though no consensus is available on the optimal training
routine, there are recommendations for short-term PFMT
[8]. However, studies on training regimens for the main-
tenance of short-term results in the long term are still
missing. Incontinence may affect the physical, psycho-
logical, and social well-being of affected individuals [3,
8, 9], but individuals are not equally affected [3].
Therefore, personalized advice would be helpful to pro-
vide high-quality treatment. Our results can contribute
to predicting who will benefit from the PFMT and what
can be done to increase the odds of achieving a suc-
cessful outcome.
Conclusion
This study suggests that a successful result after 4 months, the
performance of regular PFMT at 1 year, and older age are
predictors of long-term success in women with clinically rele-
vant SUI treatedwith a non-face-to-face training program based
on PFMT. Our results can be helpful when informing patients
with SUI about treatment based on PFMT in a clinical setting.
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